Kentucky
General Assembly

Search

House Bill 534

Actions | Amendments

Last Action	04/09/24: signed by Governor
Title	AN ACT relating to addiction treatment.
Bill Documents	Current/Final Introduced
Fiscal Impact Statements	Actuarial Analysis Local Mandate Additional Fiscal Impact Statements Exist
Bill Request Number	1792
Sponsor	R. Duvall
Summary of Original Version	Amend KRS 205.536 to prohibit the Department for Medicaid Services or a Medicaid managed care organization from requiring or using certain utilization reviews for prescription drugs that contain Naloxone; amend KRS 304.17A-611 to prohibit insurers from requiring or using certain utilization reviews for prescription drugs that contain Naloxone.
Index Headings of Original Version	Drugs and Medicines - Treatment of alcohol or opioid use disorder, Naloxone, utilization reviews, prohibition Insurance, Health - Treatment of alcohol or opioid use disorder, utilization review, Naloxone, prohibition Public Medical Assistance - Medicaid coverage, utilization review, Naloxone, prohibition State Agencies - Department for Medicaid Services, utilization review, Naloxone, prohibition State Agencies - Department of Insurance, utilization review, Naloxone, prohibition Medicaid - Department for Medicaid Services, utilization review, Naloxone, prohibition Alcoholism - Treatment, Naloxone, utilization reviews, prohibition Opioids - Treatment, Naloxone, utilization reviews, prohibition Actuarial Analysis - Treatment, Naloxone, utilization reviews, prohibition Local Mandate - Treatment of alcohol or opioid use disorder, utilization review, Naloxone, prohibition
Jump to Proposed Amendments	House Committee Substitute 1 with Fiscal Impact Statements
Votes	Vote History

Actions

Top | Amendments

02/14/24	introduced in House to Committee on Committees (H)
02/23/24	to Health Services (H)
02/29/24	reported favorably, 1st reading, to Calendar with Committee Substitute (1)
03/01/24	2nd reading, to Rules
03/05/24	posted for passage in the Regular Orders of the Day for Wednesday, March 06, 2024
03/06/24	3rd reading, passed 94-0 with Committee Substitute (1)
03/07/24	received in Senate to Committee on Committees (S)
03/13/24	to Banking & Insurance (S)
03/21/24	reported favorably, 1st reading, to Consent Calendar
03/22/24	2nd reading, to Rules as a consent bill
03/25/24	posted for passage in the Consent Orders of the Day for Tuesday, March 26, 2024
03/26/24	passed over and retained in the Consent Orders of the Day
03/27/24	passed over and retained in the Consent Orders of the Day
03/28/24	3rd reading, passed 37-1 received in House enrolled, signed by Speaker of the House enrolled, signed by President of the Senate delivered to Governor
04/09/24	signed by Governor

Proposed Amendments

Top | Actions

Amendment	House Committee Substitute 1
Fiscal Impact Statements	Actuarial Analysis to House Committee Substitute 1 Local Mandate to House Committee Substitute 1
Summary	Retain original provisions, except replace "naloxone" with "an opioid antagonist"; provide Section 2 of the Act applies to health benefit plans issued or renewed after January 1, 2025; EFFECTIVE, in part, January 2025.
Index Headings	Drugs and Medicines - Treatment of alcohol or opioid use disorder, opioid antagonist, utilization reviews, prohibition Effective Dates, Delayed - Treatment, opioid antagonist, utilization reviews, prohibition, effective January 2025, in part Insurance, Health - Treatment of alcohol or opioid use disorder, utilization review, opioid antagonist, prohibition Public Medical Assistance - Medicaid coverage, utilization review, opioid antagonist, prohibition State Agencies - Department for Medicaid Services, utilization review, opioid antagonist, prohibition State Agencies - Department of Insurance, utilization review, opioid antagonist, prohibition Medicaid - Department for Medicaid Services, utilization review, opioid antagonist, prohibition Alcoholism - Treatment, opioid antagonist, utilization reviews, prohibition Opioids - Treatment, opioid antagonist, utilization reviews, prohibition

Last updated: 4/22/2024 3:57 PM (EDT)